Status:
UNKNOWN
Accuracy of the LiverVision® Semi-automated Liver Volumetry Software
Lead Sponsor:
Royal Free Hospital NHS Foundation Trust
Collaborating Sponsors:
Ankara University
University Hospital Tuebingen
Conditions:
Liver Diseases
Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The LiverVision® software was designed to provide three-dimensional (3D) visualisation of the liver using Computed Tomography (CT) scans. It provides semi-automated volumetry measurements, vascular st...
Detailed Description
Liver volumetry has been widely used in liver surgery and living donor liver transplantation to estimate the future liver remnant or the required liver volume for the recipient, respectively. Liver v...
Eligibility Criteria
Inclusion
- Adults (18 years or older)
- Living liver donors.
Exclusion
- Recipients
Key Trial Info
Start Date :
April 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2021
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03766633
Start Date
April 29 2018
End Date
March 31 2021
Last Update
November 20 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Tübingen
Tübingen, Germany, 72076
2
Ankara Üniversitesi Tıp Fakültesi Cebeci Araştırma ve Uygulama Hastanesi
Ankara, Turkey (Türkiye), 06620
3
Royal Free Hospital
London, United Kingdom, NW3 2QG